As we have previously reported9, the Kras, Myc, and Tp53 genes have the highest frequency of genetic alterations, such as mutations, amplifications, or deletions, in human liver cancer, thus suggesting that these alterations may cooperatively drive hepatic tumorigenesis. This evidence concerns the gene MYC and liver cancer.